Opentrons Labworks Inc makes laboratory automation systems for scientists, centered on its Opentrons Flex and OT-2 liquid-handling robots, modules, pipettes, labware, software tools, and preconfigured workstations for workflows such as PCR, nucleic acid extraction, proteomics, and next-generation sequencing. Its customers include research labs and life science teams, and the company highlights use cases at institutions and companies such as Retro Biosciences, VIB Nucleomics, MilliporeSigma, YouSeq, and Cytera Cellworks. The platform combines modular hardware with no-code and low-code software, including OpentronsAI, Protocol Designer, the Opentrons App, Protocol Library, and a Python API, plus open integrations and third-party workcell support. It was started to democratize access to laboratory robotics. The founders and executives include co-founder and CEO Noah Medlock, Chief Financial Officer Michael V. Purcell, and Chief Product Officer James Atwood. The business has robots in labs in more than 50 countries and has raised over $200 million in funding, including unicorn-status financing.